Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

NCT00558298 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

NCT00495118 ·Status: COMPLETED ·Phase: PHASE3

A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

NCT00210691 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

NCT01855074 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

NCT00249223 ·Status: COMPLETED ·Phase: PHASE3

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

NCT01726335 ·Status: COMPLETED ·Phase: PHASE4

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

NCT00216580 ·Status: COMPLETED ·Phase: PHASE3

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

NCT00216632 ·Status: COMPLETED ·Phase: PHASE4

An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

NCT00992407 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients

NCT00653406 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

NCT01894984 ·Status: TERMINATED

RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

NCT00458367 ·Status: COMPLETED

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

NCT00539071 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

NCT00240708 ·Status: COMPLETED ·Phase: PHASE3

An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder

NCT02186769 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

NCT00236457 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

NCT00563017 ·Status: UNKNOWN ·Phase: NA

An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia

NCT00269919 ·Status: COMPLETED ·Phase: PHASE4

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

NCT00246259 ·Status: COMPLETED ·Phase: PHASE4

Bioavailability of LY03004 and Risperdal® Consta®

NCT02091388 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres

NCT00216528 ·Status: COMPLETED ·Phase: PHASE4

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

NCT00246194 ·Status: COMPLETED

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

NCT00246246 ·Status: COMPLETED ·Phase: PHASE3

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

NCT00216671 ·Status: COMPLETED ·Phase: PHASE4

Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis

NCT00369239 ·Status: COMPLETED ·Phase: PHASE4